Robert Barry

Ph.D.

Robert Barry, Ph.D is the Director of Scientific Affairs for Kaneka Nutrients. He focuses on clinical research development and collaboration, as well as the development of the technical, business and commercial translation of products and technology for Kaneka Nutrients, Kaneka QHTM (Ubiquinol) and other health-related products.

Dr. Barry brings over 20 years of strategic technical development and commercial translation of scientific products, analytical services, drug development and pre-clinical evaluation systems to his position. Prior to joining Kaneka, he co-founded and served as the president of a Massachusetts-based drug development company. Under Dr. Barry’s direction, the company identified new lead-drug candidates, focusing on unmet clinical needs in several disease areas.

He is an active member of numerous professional associations, including:

  • The American Chemical Society
  • The American Association for the Advancement of Science
  • Mitochondria Research Society
  • American Burn Association
  • The International Coenzyme Q10 Association


Published Work, Presentations and Advisories

Dr. Barry has presented at nearly all Kaneka Nutrients professional venues. He was a Principal Advisor for NIH, specializing in the commercial development of biotech start-up companies, their technologies and products.
He also founded and served as president of a premier independent testing laboratory and scientific research company serving the natural products industry. Prior to that, Dr. Barry developed a natural products division for a major analytical device company where he served as vice president and chief technical officer.

Education

Dr. Barry earned his bachelor’s degree in Biology from Boston College; his Ph.D. in Chemistry/Biochemistry from the University of Maryland; postdoctoral research in Biological Chemistry and Molecular Pharmacology at Harvard Medical School; and was a staff researcher in neuropathology at Harvard Medical School.